News | Information Technology | September 29, 2023

Fuse also announces Syntyant, a new interoperable platform for RadOnc providing seamless connectivity among diverse healthcare technologies to accelerate delivery of care 

Fuse also announces Syntyant, a new interoperable platform for RadOnc providing seamless connectivity among diverse healthcare technologies to accelerate delivery of care

September 29, 2023 — Fuse Oncology (Fuse) a trailblazing leader in radiation oncology software solutions, unveils their latest pioneering product, FuseDocs, today. This groundbreaking software leverages generative artificial intelligence (AI) to transform radiation oncology documentation, allowing oncologists to refocus their energies on patient care.  

FuseDocs automatically and effortlessly generates clinical documentation, drastically reducing the time needed to produce essential records. By accurately generating the correct documents at the right time, human errors are reduced while ensuring compliance with regulatory requirements.  

President of Radiation Oncology Associates, PC, and the emeritus Chairman and Medical Director of the Department for Advanced Radiation Oncology and Proton Therapy for Inova Schar Cancer Institute Gopal K. Bajaj, MD MBA FASTRO said, “Fuse is not only introducing a product—they are ushering in a new era of efficiency and innovation in radiation oncology. Their mission is clearly being realized—to empower radiation oncologists to provide the best care possible, and FuseDocs is a significant step in that direction.”  

FuseDocs represents a pivotal advancement in the field of radiation oncology. By replacing template-based approaches with fully automated documentation that leverages generative AI, the administrative burden is significantly reduced—empowering radiation oncologists to focus on what truly matters— providing exceptional patient care.  

“We’re excited to introduce FuseDocs to the radiation oncology community at ASTRO,” said Fuse CEO James Bauler. “Our software leverages generative AI to create unprecedented efficiencies, enabling radiation oncologists to invest their time and talent in patient care, unburdened by administrative tasks. FuseDocs moves RadOnc one step closer to delivering care at the speed of the patient.”  

FuseDocs builds upon the success of Fuse’s existing product, S!GNAL, which is creating a RadOnc world where workflows are automatically monitored for consistent adherence. A simple secure dashboard provides real-time feedback to assist healthcare systems and RadOnc clinics discover revenue opportunities by detecting missing documentation, incomplete tasks and errors in charge capture.  

Along with FuseDocs, Fuse also unveiled today their interoperable platform for RadOnc, Syntyant, which provides seamless connectivity among diverse healthcare technologies including EMR, OIS, and planning systems to accelerate delivery of care.  

Fuse will be at booth #1618 at the ASTRO conference from October 1-4 to showcase their suite of products and offer live FuseDocs demos.   

For more information: www.fuseonc.com 

Find more ASTRO23 conference coverage here


Related Content

News | PACS

July 8, 2026 — Freeland Systems, a cloud PACS and clinical imaging software company, has launched its new customer ...

Time July 10, 2026
arrow
News | Ultrasound Imaging

July 7, 2026 — Longeviti Neuro Solutions has launched a new strategic initiative, ClearFit AI, a Brain Ultrasound ...

Time July 09, 2026
arrow
News | Prostate Cancer

July 8,2026 — CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, has announced the ...

Time July 08, 2026
arrow
News | Women's Health

July 1, 2026 — Despite declining birth rates worldwide, the complexity of pregnancy is increasing. Advanced maternal age ...

Time July 01, 2026
arrow
News | Information Technology

June 26, 2026 — Radin Health recently announced the successful deployment of its cloud-native platform at four ...

Time June 26, 2026
arrow
News | FDA

June 25, 2026 — Aidoc recently announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device ...

Time June 25, 2026
arrow
News | Mammography

June 23, 2026 — Using artificial intelligence (AI), researchers found that image-based risk scores for breast cancer ...

Time June 24, 2026
arrow
News | Pediatric Imaging

June 16, 2026 — Crescom has officially launched a global clinical Proof of Concept (PoC) of its pediatric ...

Time June 24, 2026
arrow
News | Information Technology

June 24, 2026 — HOPPR Presto Agent (Presto) is now commercially available from HOPPR. Presto iis a tool that ntegrates ...

Time June 24, 2026
arrow
News | Digital Pathology

June 17, 2026 — Proscia has introduced the Fifth Generation of its Concentriq1 platform, helping pathologists focus on ...

Time June 22, 2026
arrow
Subscribe Now